PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
18-Dec-2019 MR Solutions participates in the first nanomedicine joint annual meeting in Dijon MR Solutions
18-Dec-2019 Domain Therapeutics and Pr Michel Bouvier (IRIC Montreal) receive the RSRI award for bioSens-All™ project at ADRIQ-RCTi Innovation Prize gala Domain Therapeutics
18-Dec-2019 Sanofi Wins Prestigious Drug Discovery Award for Innovative Rare Blood Clotting Disorder Treatment[1] Sanofi
18-Dec-2019 Newcells Biotech Win Phase II of CRACK IT Challenge 29: ImmuLiver Newcells Biotech
18-Dec-2019 World first treatment with ‘acoustic cluster therapy’ to improve chemotherapy delivery The Institute of Cancer Research
18-Dec-2019 Cycle For Survival's Gift This December: A Super Microscope To Outsmart Cancer Cycle for Survival
18-Dec-2019 Vaccitech Oncology Limited enters collaboration with Cancer Research UK to fund a Phase I/IIa clinical trial as first-line NSCLC therapy Vaccitech Ltd
18-Dec-2019 Seven Bridges Announces Mike Bigda as Chief Operating Officer Seven Bridges
18-Dec-2019 Pathios Therapeutics closes US$8.8M Series A and appoints Stuart Hughes as CEO Pathios Therapeutics
18-Dec-2019 REGENXBIO Announces Interim Data from Phase I/II Trial of RGX-121 for the Treatment of Mucopolysaccharidosis Type II (MPS II) REGENXBIO Inc.
18-Dec-2019 Ionis appoints C. Frank Bennett, Ph.D., to chief scientific officer and promotes Eric E. Swayze, Ph.D., to senior vice president of research Ionis Pharmaceuticals, Inc.
17-Dec-2019 Achieve Life Sciences Announces Pricing of $12 Million Underwritten Public Offering Achieve Life Sciences, Inc.
17-Dec-2019 Novartis receives positive CHMP opinion for Beovu® (brolucizumab) for the treatment of wet AMD Novartis UK
17-Dec-2019 NICE recommends Vifor Pharma’s Veltassa® (patiromer) for adults with hyperkalaemia in England[i] Vifor Pharma UK
17-Dec-2019 From cancer medication to antibiotic: modified cancer drug effective against multi-resistant bacteria TECHNICAL UNIVERSITY OF MUNICH
17-Dec-2019 MEI Pharma Announces Pricing of Public Offering of Common Stock MEI Pharma, Inc.
17-Dec-2019 Enhanced production technology enables InSphero to reduce pricing of 3D InSight(TM) Human Liver Microtissues for broader access to assay-ready spheroid technology InSphero
17-Dec-2019 CNS Pharmaceuticals Partnered with Anthem Biosciences Pvt. Ltd. in Preparation for Upcoming Proposed Phase 2 Clinical Trial CNS Pharmaceuticals, Inc.
17-Dec-2019 Alligator Bioscience: First Patient Dosed With ATOR-1017 Developed for Metastasized Cancer Alligator Bioscience
17-Dec-2019 Bio-Techne's Exosome Diagnostics Lab Receives Accreditation From College of American Pathologists (CAP) Bio-Techne Corporation